NEW YORK (GenomeWeb) – Qiagen and Biotype Diagnostics today announced a joint venture establishing Biotype Innovation to develop and commercialize molecular diagnostic workflows. 

The workflows to be developed will be initially for personalized healthcare applications based on Qiagen's ModaPlex platform for detecting, characterizing, and measuring up to 100 parameters cost effectively and rapidly. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.